Trial Profile
Early evaluation of the sorafenib efficacy in advanced hepatocellular carcinoma patients using duplex Doppler ultrasonography (DDU).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 14 Dec 2015 New trial record